Effect of Exercise Training on Estimated GFR, Vascular Health, and Cardiorespiratory Fitness in Patients with CKD: a Pilot Randomized Controlled Trial
Overview
Authors
Affiliations
Background: Exercise capacity, which is predictive of all-cause mortality and cardiovascular disease risk, is reduced significantly in patients with non-dialysis-dependent chronic kidney disease. This pilot study examined the effect of moderate-intensity exercise training on kidney function and indexes of cardiovascular risk in patients with progressive chronic kidney disease stages 3 to 4.
Study Design: Single-blind, randomized, controlled, parallel trial.
Setting & Participants: 20 patients (aged 18-80 years; 17 men) randomly assigned to rehabilitation (n=10) or usual care (n=10). Participants were included if they were 18 years or older and had evidence of rate of decline in creatinine-based estimated glomerular filtration rate (eGFRcr)≥2.9mL/min/1.73m(2) per year for 12 months preintervention. Patients were excluded if they had unstable medical conditions or had recently started regular exercise.
Intervention: The rehabilitation group received resistance and aerobic training (3 days per week) for a 12-month period. The usual care group received standard care.
Outcomes: Kidney function assessed by comparing mean rate of change in eGFRcr (mL/min/1.73m(2) per year) from a 12-month preintervention period against the 12-month intervention period. Pulse wave velocity (PWV), peak oxygen uptake (Vo2peak), and waist circumference assessed at 0, 6, and 12 months.
Measurements: eGFR assessed using creatinine, cystatin C (eGFRcys), and a combination of both values (eGFRcr-cys).
Results: 18 participants (rehabilitation, 8; usual care, 10) completed the study. A significant mean difference in rate of change in eGFRcr (+7.8±3.0 [95% CI, 1.1-13.5] mL/min/1.73m(2) per year; P=0.02) was observed between the rehabilitation and usual care groups, with the rehabilitation group demonstrating a slower decline. No significant between-group mean differences existed in absolute eGFRcr, eGFRcr-cys, or eGFRcys at 12 months of study intervention. Significant between-group mean differences existed in PWV (-2.30 [95% CI, -3.02 to -1.59] m/s), waist circumference (-7.1±12.8 [95% CI, -12.4 to -3.2] cm), and Vo2peak (5.7 [95% CI, 1.34-10.10] mL/kg/min). Change in eGFRcr was correlated inversely with PWV (r=-0.5; P=0.04) at 12 months.
Limitations: Small sample size, inconsistency between primary and secondary measures of kidney function.
Conclusions: The effect of a 1-year exercise intervention on progression of kidney disease is inconclusive. A larger study with longer follow-up may be necessary.
Hori S, Tomizawa M, Inoue K, Yoneda T, Onishi K, Morizawa Y BMC Nephrol. 2025; 26(1):28.
PMID: 39825248 PMC: 11740693. DOI: 10.1186/s12882-024-03850-1.
Review of Exercise Interventions to Improve Clinical Outcomes in Nondialysis CKD.
Hayden C, Begue G, Gamboa J, Baar K, Roshanravan B Kidney Int Rep. 2024; 9(11):3097-3115.
PMID: 39534200 PMC: 11551061. DOI: 10.1016/j.ekir.2024.07.032.
Traise A, Dieberg G, Pearson M, Smart N J Nephrol. 2024; 37(8):2063-2098.
PMID: 39417982 PMC: 11649798. DOI: 10.1007/s40620-024-02081-9.
Treatment of chronic kidney disease in older populations.
Kishi S, Kadoya H, Kashihara N Nat Rev Nephrol. 2024; 20(9):586-602.
PMID: 38977884 DOI: 10.1038/s41581-024-00854-w.
Liu C, Yang J, Li H, Deng Y, He P, Zhang J Ren Fail. 2024; 46(2):2373272.
PMID: 38967189 PMC: 467113. DOI: 10.1080/0886022X.2024.2373272.